| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atherosclerosis | 35 | 2018 | 693 | 3.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 31 | 2019 | 1379 | 2.780 |
Why?
|
| Macaca fascicularis | 63 | 2019 | 389 | 2.660 |
Why?
|
| Whole-Body Irradiation | 6 | 2019 | 48 | 2.320 |
Why?
|
| Bone Density | 18 | 2018 | 182 | 2.300 |
Why?
|
| Estrogens | 16 | 2018 | 162 | 1.970 |
Why?
|
| Isoflavones | 19 | 2015 | 65 | 1.950 |
Why?
|
| Ovariectomy | 30 | 2018 | 147 | 1.850 |
Why?
|
| Soybean Proteins | 17 | 2016 | 64 | 1.730 |
Why?
|
| Estradiol | 11 | 2018 | 118 | 1.720 |
Why?
|
| Animals | 97 | 2019 | 7297 | 1.640 |
Why?
|
| African Americans | 20 | 2018 | 1373 | 1.540 |
Why?
|
| Carotid Artery Diseases | 7 | 2017 | 109 | 1.530 |
Why?
|
| Heart | 7 | 2018 | 161 | 1.470 |
Why?
|
| Female | 124 | 2019 | 18164 | 1.370 |
Why?
|
| Postmenopause | 19 | 2018 | 397 | 1.300 |
Why?
|
| Sertraline | 6 | 2017 | 27 | 1.220 |
Why?
|
| Iliac Artery | 9 | 2015 | 46 | 1.140 |
Why?
|
| Vitamin D | 4 | 2016 | 171 | 1.110 |
Why?
|
| Monocytes | 5 | 2019 | 119 | 1.080 |
Why?
|
| Disease Models, Animal | 27 | 2018 | 980 | 1.030 |
Why?
|
| Mammary Glands, Animal | 13 | 2016 | 46 | 1.030 |
Why?
|
| Calcinosis | 10 | 2016 | 143 | 1.030 |
Why?
|
| Diet, Mediterranean | 3 | 2019 | 23 | 1.030 |
Why?
|
| Adipose Tissue | 8 | 2018 | 327 | 0.990 |
Why?
|
| Obesity | 9 | 2019 | 1063 | 0.980 |
Why?
|
| Myocardium | 5 | 2018 | 170 | 0.950 |
Why?
|
| Depression | 7 | 2017 | 380 | 0.930 |
Why?
|
| T-Lymphocytes | 6 | 2019 | 114 | 0.900 |
Why?
|
| Transcription, Genetic | 4 | 2019 | 136 | 0.870 |
Why?
|
| Estrogens, Conjugated (USP) | 12 | 2013 | 125 | 0.850 |
Why?
|
| Gene Expression Regulation | 12 | 2019 | 481 | 0.840 |
Why?
|
| Extracellular Matrix | 5 | 2018 | 226 | 0.830 |
Why?
|
| Coronary Vessels | 11 | 2018 | 147 | 0.800 |
Why?
|
| Body Composition | 7 | 2019 | 365 | 0.790 |
Why?
|
| Albuminuria | 5 | 2017 | 176 | 0.780 |
Why?
|
| Gene Expression | 5 | 2018 | 332 | 0.770 |
Why?
|
| Soybeans | 8 | 2014 | 25 | 0.750 |
Why?
|
| Fatty Liver | 2 | 2019 | 66 | 0.750 |
Why?
|
| Receptors, Estrogen | 8 | 2016 | 89 | 0.740 |
Why?
|
| Gamma Rays | 2 | 2019 | 24 | 0.740 |
Why?
|
| Calcium | 4 | 2018 | 296 | 0.740 |
Why?
|
| Male | 59 | 2019 | 17807 | 0.730 |
Why?
|
| Fibroblast Growth Factors | 3 | 2017 | 34 | 0.730 |
Why?
|
| Aging | 10 | 2017 | 881 | 0.690 |
Why?
|
| Adiponectin | 4 | 2013 | 103 | 0.680 |
Why?
|
| Energy Intake | 2 | 2019 | 120 | 0.680 |
Why?
|
| Homeostasis | 2 | 2018 | 127 | 0.670 |
Why?
|
| Adiposity | 4 | 2016 | 191 | 0.670 |
Why?
|
| Diastole | 1 | 2018 | 90 | 0.660 |
Why?
|
| Coronary Artery Disease | 9 | 2018 | 359 | 0.660 |
Why?
|
| Serotonin Uptake Inhibitors | 5 | 2017 | 35 | 0.660 |
Why?
|
| Middle Aged | 41 | 2018 | 10829 | 0.650 |
Why?
|
| Estrogen Replacement Therapy | 10 | 2012 | 182 | 0.630 |
Why?
|
| Humans | 69 | 2019 | 29093 | 0.620 |
Why?
|
| Arteries | 3 | 2016 | 60 | 0.620 |
Why?
|
| Random Allocation | 16 | 2018 | 213 | 0.610 |
Why?
|
| Immunohistochemistry | 6 | 2018 | 519 | 0.610 |
Why?
|
| Aged | 33 | 2018 | 9487 | 0.580 |
Why?
|
| Cross-Sectional Studies | 10 | 2018 | 1356 | 0.570 |
Why?
|
| Time Factors | 11 | 2019 | 2001 | 0.550 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2015 | 10 | 0.540 |
Why?
|
| Cytokines | 2 | 2015 | 243 | 0.530 |
Why?
|
| Energy Metabolism | 4 | 2019 | 139 | 0.530 |
Why?
|
| Diabetic Angiopathies | 3 | 2013 | 137 | 0.520 |
Why?
|
| Polymorphism, Single Nucleotide | 10 | 2017 | 1079 | 0.510 |
Why?
|
| Bone Morphogenetic Proteins | 2 | 2014 | 24 | 0.510 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2018 | 100 | 0.490 |
Why?
|
| Norpregnenes | 6 | 2013 | 16 | 0.490 |
Why?
|
| Antigens, CD | 2 | 2015 | 100 | 0.480 |
Why?
|
| Lipids | 5 | 2016 | 209 | 0.470 |
Why?
|
| Muscle, Skeletal | 6 | 2019 | 494 | 0.460 |
Why?
|
| Inflammation | 3 | 2013 | 507 | 0.450 |
Why?
|
| Diet, Atherogenic | 11 | 2018 | 61 | 0.450 |
Why?
|
| Behavior, Animal | 5 | 2015 | 264 | 0.450 |
Why?
|
| Alcohol Drinking | 4 | 2004 | 244 | 0.450 |
Why?
|
| Chemokine CCL2 | 5 | 2018 | 47 | 0.440 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2014 | 268 | 0.430 |
Why?
|
| Body Mass Index | 9 | 2016 | 865 | 0.400 |
Why?
|
| Cardiovascular Diseases | 7 | 2018 | 1013 | 0.400 |
Why?
|
| Continental Population Groups | 1 | 2012 | 221 | 0.390 |
Why?
|
| Diet | 12 | 2016 | 354 | 0.380 |
Why?
|
| Estrogen Receptor Modulators | 4 | 2013 | 23 | 0.370 |
Why?
|
| Haplorhini | 7 | 2019 | 64 | 0.370 |
Why?
|
| Selective Estrogen Receptor Modulators | 5 | 2013 | 29 | 0.370 |
Why?
|
| Body Weight | 6 | 2016 | 290 | 0.360 |
Why?
|
| Estrogen Receptor alpha | 7 | 2018 | 50 | 0.360 |
Why?
|
| Arteriosclerosis | 3 | 2004 | 116 | 0.360 |
Why?
|
| Macaca mulatta | 4 | 2019 | 322 | 0.360 |
Why?
|
| Adult | 19 | 2019 | 8420 | 0.350 |
Why?
|
| Progesterone | 7 | 2014 | 80 | 0.350 |
Why?
|
| Risk Factors | 18 | 2017 | 3531 | 0.350 |
Why?
|
| Apolipoproteins E | 5 | 2018 | 97 | 0.340 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2007 | 41 | 0.340 |
Why?
|
| Medroxyprogesterone Acetate | 9 | 2008 | 89 | 0.330 |
Why?
|
| Breast | 5 | 2013 | 53 | 0.330 |
Why?
|
| Premenopause | 5 | 2018 | 38 | 0.330 |
Why?
|
| Spine | 3 | 2018 | 38 | 0.330 |
Why?
|
| Mitochondria, Muscle | 2 | 2019 | 17 | 0.320 |
Why?
|
| Liver | 4 | 2009 | 464 | 0.310 |
Why?
|
| Women's Health | 1 | 2009 | 226 | 0.310 |
Why?
|
| Tomography, X-Ray Computed | 9 | 2018 | 871 | 0.310 |
Why?
|
| Gene Expression Profiling | 7 | 2015 | 320 | 0.310 |
Why?
|
| Stress, Psychological | 5 | 2013 | 208 | 0.300 |
Why?
|
| Hippocampus | 3 | 2016 | 185 | 0.300 |
Why?
|
| Motor Activity | 6 | 2014 | 310 | 0.300 |
Why?
|
| Aggression | 3 | 2007 | 29 | 0.300 |
Why?
|
| Bone Diseases, Metabolic | 4 | 2014 | 20 | 0.300 |
Why?
|
| Longitudinal Studies | 7 | 2018 | 720 | 0.290 |
Why?
|
| Cholesterol | 5 | 2018 | 229 | 0.290 |
Why?
|
| Lipoproteins, HDL | 2 | 2014 | 247 | 0.290 |
Why?
|
| Ethanol | 3 | 2004 | 185 | 0.290 |
Why?
|
| Social Behavior | 5 | 2013 | 67 | 0.290 |
Why?
|
| Antidepressive Agents | 2 | 2017 | 70 | 0.290 |
Why?
|
| Dose-Response Relationship, Radiation | 4 | 2019 | 76 | 0.280 |
Why?
|
| Matrix Metalloproteinase 9 | 3 | 2013 | 31 | 0.280 |
Why?
|
| Mammary Glands, Human | 2 | 2018 | 15 | 0.270 |
Why?
|
| Models, Animal | 6 | 2016 | 160 | 0.260 |
Why?
|
| Breast Neoplasms | 7 | 2013 | 666 | 0.260 |
Why?
|
| Phosphates | 2 | 2015 | 25 | 0.260 |
Why?
|
| Mortality | 2 | 2017 | 109 | 0.260 |
Why?
|
| Uterus | 5 | 2017 | 73 | 0.260 |
Why?
|
| Weight Loss | 2 | 2018 | 413 | 0.260 |
Why?
|
| European Continental Ancestry Group | 9 | 2017 | 1131 | 0.250 |
Why?
|
| Bone and Bones | 3 | 2018 | 87 | 0.240 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2003 | 2 | 0.240 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2003 | 10 | 0.240 |
Why?
|
| Primates | 3 | 2019 | 100 | 0.240 |
Why?
|
| Organ Size | 5 | 2016 | 196 | 0.230 |
Why?
|
| Phytoestrogens | 4 | 2016 | 16 | 0.230 |
Why?
|
| Object Attachment | 1 | 2002 | 2 | 0.220 |
Why?
|
| Indoles | 2 | 2013 | 58 | 0.220 |
Why?
|
| Androgen Antagonists | 1 | 2002 | 15 | 0.220 |
Why?
|
| Alzheimer Disease | 2 | 2018 | 312 | 0.220 |
Why?
|
| Macrophages | 3 | 2015 | 188 | 0.210 |
Why?
|
| Linkage Disequilibrium | 4 | 2016 | 192 | 0.210 |
Why?
|
| Follow-Up Studies | 7 | 2017 | 2108 | 0.210 |
Why?
|
| C-Reactive Protein | 2 | 2013 | 232 | 0.210 |
Why?
|
| Ovary | 3 | 2017 | 54 | 0.210 |
Why?
|
| Depressive Disorder | 2 | 2015 | 74 | 0.210 |
Why?
|
| Absorptiometry, Photon | 6 | 2018 | 129 | 0.200 |
Why?
|
| Hormone Replacement Therapy | 3 | 2017 | 86 | 0.200 |
Why?
|
| Intra-Abdominal Fat | 2 | 2013 | 61 | 0.200 |
Why?
|
| Kidney Diseases | 2 | 2014 | 239 | 0.190 |
Why?
|
| Foam Cells | 2 | 2010 | 11 | 0.190 |
Why?
|
| Cell Proliferation | 7 | 2013 | 573 | 0.190 |
Why?
|
| Peptide Fragments | 3 | 2013 | 422 | 0.190 |
Why?
|
| Drug Administration Schedule | 4 | 2016 | 246 | 0.190 |
Why?
|
| Progestins | 2 | 2013 | 18 | 0.190 |
Why?
|
| Phenotype | 4 | 2016 | 629 | 0.190 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2012 | 152 | 0.190 |
Why?
|
| Glomerular Filtration Rate | 3 | 2017 | 287 | 0.190 |
Why?
|
| Aged, 80 and over | 11 | 2018 | 3717 | 0.180 |
Why?
|
| Contraceptives, Oral | 3 | 2008 | 20 | 0.180 |
Why?
|
| Mice | 11 | 2018 | 2368 | 0.180 |
Why?
|
| Genome-Wide Association Study | 3 | 2017 | 543 | 0.180 |
Why?
|
| Cell Polarity | 1 | 2019 | 14 | 0.180 |
Why?
|
| Drug Evaluation, Preclinical | 3 | 2014 | 58 | 0.180 |
Why?
|
| Peptides | 2 | 2018 | 118 | 0.180 |
Why?
|
| Health Status | 1 | 2002 | 368 | 0.180 |
Why?
|
| Hematopoietic System | 1 | 2019 | 3 | 0.170 |
Why?
|
| Radiation Injuries, Experimental | 2 | 2019 | 33 | 0.170 |
Why?
|
| Kidney Function Tests | 2 | 2017 | 102 | 0.170 |
Why?
|
| Immunity | 1 | 2019 | 19 | 0.170 |
Why?
|
| Severity of Illness Index | 2 | 2013 | 863 | 0.170 |
Why?
|
| Aromatase | 1 | 2018 | 6 | 0.170 |
Why?
|
| Disease Progression | 3 | 2016 | 572 | 0.170 |
Why?
|
| Genetic Association Studies | 2 | 2016 | 148 | 0.170 |
Why?
|
| Endometrium | 5 | 2013 | 120 | 0.170 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2016 | 836 | 0.170 |
Why?
|
| Sexual Maturation | 2 | 2016 | 26 | 0.170 |
Why?
|
| Postoperative Period | 1 | 2018 | 91 | 0.170 |
Why?
|
| Elastin | 2 | 2016 | 14 | 0.160 |
Why?
|
| Signal Transduction | 5 | 2013 | 666 | 0.160 |
Why?
|
| RNA | 2 | 2013 | 88 | 0.160 |
Why?
|
| Psoas Muscles | 1 | 2018 | 19 | 0.160 |
Why?
|
| Granulosa Cells | 1 | 2017 | 11 | 0.160 |
Why?
|
| Dietary Proteins | 3 | 2014 | 50 | 0.160 |
Why?
|
| Macaca | 2 | 2018 | 25 | 0.160 |
Why?
|
| Radius | 1 | 2017 | 21 | 0.160 |
Why?
|
| Insulin | 2 | 2019 | 346 | 0.160 |
Why?
|
| Collagen Type I | 3 | 2013 | 39 | 0.160 |
Why?
|
| Diabetes Complications | 3 | 2013 | 171 | 0.160 |
Why?
|
| Sex Factors | 3 | 2017 | 631 | 0.160 |
Why?
|
| Protein Phosphatase 1 | 1 | 2017 | 5 | 0.160 |
Why?
|
| Carotid Artery, Common | 1 | 2017 | 37 | 0.150 |
Why?
|
| Calpain | 1 | 2017 | 12 | 0.150 |
Why?
|
| Lipolysis | 1 | 2017 | 17 | 0.150 |
Why?
|
| Carotid Arteries | 2 | 2015 | 97 | 0.150 |
Why?
|
| Sulfonamides | 1 | 2017 | 65 | 0.150 |
Why?
|
| Collagen | 2 | 2016 | 217 | 0.150 |
Why?
|
| Excitatory Amino Acid Transporter 1 | 1 | 2016 | 3 | 0.150 |
Why?
|
| Lipoproteins | 4 | 2006 | 82 | 0.150 |
Why?
|
| Receptor, EphB2 | 1 | 2016 | 6 | 0.150 |
Why?
|
| Mitochondria, Heart | 1 | 2016 | 16 | 0.150 |
Why?
|
| Blood Platelets | 1 | 2016 | 37 | 0.140 |
Why?
|
| Ethnic Groups | 3 | 2014 | 440 | 0.140 |
Why?
|
| Carbohydrate Metabolism | 1 | 2016 | 13 | 0.140 |
Why?
|
| Tissue Fixation | 1 | 2016 | 10 | 0.140 |
Why?
|
| Subcutaneous Fat | 1 | 2016 | 42 | 0.140 |
Why?
|
| Paraffin Embedding | 1 | 2016 | 10 | 0.140 |
Why?
|
| Spinal Fractures | 1 | 2016 | 42 | 0.140 |
Why?
|
| Parathyroid Hormone | 1 | 2016 | 38 | 0.140 |
Why?
|
| Workflow | 1 | 2016 | 20 | 0.140 |
Why?
|
| Genotype | 6 | 2017 | 735 | 0.140 |
Why?
|
| Sex Characteristics | 3 | 2013 | 167 | 0.140 |
Why?
|
| DNA Methylation | 2 | 2015 | 130 | 0.140 |
Why?
|
| Aortic Diseases | 1 | 2016 | 54 | 0.140 |
Why?
|
| Frozen Sections | 1 | 2016 | 18 | 0.140 |
Why?
|
| Dominance-Subordination | 3 | 2005 | 15 | 0.140 |
Why?
|
| Fatty Acids | 2 | 2019 | 92 | 0.140 |
Why?
|
| Matrix Metalloproteinases, Secreted | 1 | 2015 | 3 | 0.130 |
Why?
|
| Prostatic Neoplasms | 2 | 2013 | 441 | 0.130 |
Why?
|
| Cholesterol, HDL | 2 | 2013 | 165 | 0.130 |
Why?
|
| Menopause | 2 | 2013 | 86 | 0.130 |
Why?
|
| Menisci, Tibial | 1 | 2015 | 24 | 0.130 |
Why?
|
| Myosin Heavy Chains | 2 | 2012 | 86 | 0.130 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2012 | 104 | 0.130 |
Why?
|
| Substance P | 1 | 2014 | 22 | 0.130 |
Why?
|
| Thyroid Hormones | 1 | 2014 | 5 | 0.130 |
Why?
|
| Upper Extremity | 1 | 2015 | 52 | 0.130 |
Why?
|
| Cell Differentiation | 2 | 2016 | 436 | 0.130 |
Why?
|
| Rotator Cuff | 1 | 2015 | 67 | 0.130 |
Why?
|
| Exercise | 2 | 2018 | 591 | 0.130 |
Why?
|
| Osteoarthritis, Knee | 1 | 2015 | 80 | 0.130 |
Why?
|
| Radiography | 5 | 2015 | 353 | 0.120 |
Why?
|
| Wnt1 Protein | 1 | 2014 | 3 | 0.120 |
Why?
|
| Fibroblasts | 1 | 2014 | 103 | 0.120 |
Why?
|
| Renin-Angiotensin System | 1 | 2015 | 182 | 0.120 |
Why?
|
| Dentate Gyrus | 1 | 2014 | 6 | 0.120 |
Why?
|
| Pathology, Clinical | 1 | 2014 | 14 | 0.120 |
Why?
|
| Knee Joint | 1 | 2015 | 129 | 0.120 |
Why?
|
| Biogenic Monoamines | 1 | 2013 | 4 | 0.120 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2014 | 26 | 0.120 |
Why?
|
| Neuroglia | 1 | 2014 | 29 | 0.120 |
Why?
|
| Brain | 2 | 2018 | 930 | 0.120 |
Why?
|
| Plant Preparations | 2 | 2004 | 21 | 0.120 |
Why?
|
| Genetic Markers | 1 | 2013 | 122 | 0.120 |
Why?
|
| Hierarchy, Social | 2 | 2013 | 24 | 0.120 |
Why?
|
| Mammography | 1 | 2013 | 37 | 0.120 |
Why?
|
| Puberty | 1 | 2013 | 8 | 0.120 |
Why?
|
| Dietary Supplements | 1 | 2015 | 170 | 0.120 |
Why?
|
| Bone Resorption | 1 | 2013 | 13 | 0.120 |
Why?
|
| African Continental Ancestry Group | 4 | 2010 | 350 | 0.110 |
Why?
|
| Synapses | 1 | 2014 | 85 | 0.110 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 366 | 0.110 |
Why?
|
| Osmolar Concentration | 1 | 2012 | 17 | 0.110 |
Why?
|
| Endometrial Hyperplasia | 2 | 2013 | 14 | 0.110 |
Why?
|
| Calcifediol | 1 | 2012 | 7 | 0.110 |
Why?
|
| Diabetic Nephropathies | 1 | 2014 | 195 | 0.110 |
Why?
|
| Calcification, Physiologic | 1 | 2012 | 9 | 0.110 |
Why?
|
| Mobility Limitation | 1 | 2014 | 187 | 0.110 |
Why?
|
| Apolipoproteins | 1 | 2014 | 196 | 0.110 |
Why?
|
| Osteoarthritis | 1 | 2013 | 74 | 0.110 |
Why?
|
| Quadriceps Muscle | 1 | 2012 | 31 | 0.110 |
Why?
|
| Pterocarpans | 1 | 2011 | 4 | 0.110 |
Why?
|
| Blood Glucose | 4 | 2019 | 466 | 0.110 |
Why?
|
| Apoptosis | 3 | 2013 | 337 | 0.100 |
Why?
|
| Aorta, Abdominal | 1 | 2011 | 26 | 0.100 |
Why?
|
| bcl-Associated Death Protein | 2 | 2013 | 6 | 0.100 |
Why?
|
| Cognition Disorders | 1 | 2015 | 390 | 0.100 |
Why?
|
| Housing, Animal | 1 | 2011 | 23 | 0.100 |
Why?
|
| Lumbar Vertebrae | 4 | 2017 | 98 | 0.100 |
Why?
|
| Chromosome Mapping | 1 | 2012 | 190 | 0.100 |
Why?
|
| Electrocardiography | 1 | 2016 | 562 | 0.100 |
Why?
|
| Epinephrine | 2 | 2013 | 41 | 0.100 |
Why?
|
| Collagen Type III | 1 | 2011 | 13 | 0.100 |
Why?
|
| Blood Pressure | 1 | 2015 | 804 | 0.100 |
Why?
|
| Gait | 1 | 2011 | 115 | 0.100 |
Why?
|
| Thoracic Vertebrae | 2 | 2017 | 42 | 0.100 |
Why?
|
| Shoulder Joint | 1 | 2013 | 123 | 0.100 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 2010 | 3 | 0.100 |
Why?
|
| Peptide Hydrolases | 1 | 2010 | 15 | 0.100 |
Why?
|
| Analysis of Variance | 4 | 2017 | 454 | 0.100 |
Why?
|
| Cathepsin K | 1 | 2010 | 3 | 0.090 |
Why?
|
| Pericardium | 1 | 2010 | 50 | 0.090 |
Why?
|
| Isoenzymes | 1 | 2010 | 63 | 0.090 |
Why?
|
| Antioxidants | 1 | 2011 | 114 | 0.090 |
Why?
|
| Sterol O-Acyltransferase | 1 | 2009 | 11 | 0.090 |
Why?
|
| Drug Therapy, Combination | 4 | 2002 | 273 | 0.090 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2009 | 18 | 0.090 |
Why?
|
| RNA, Messenger | 4 | 2015 | 514 | 0.090 |
Why?
|
| Estrogen Receptor beta | 2 | 2007 | 12 | 0.090 |
Why?
|
| Adaptation, Biological | 1 | 2009 | 8 | 0.090 |
Why?
|
| Carotid Stenosis | 1 | 2010 | 56 | 0.090 |
Why?
|
| Blood Vessels | 1 | 2009 | 47 | 0.090 |
Why?
|
| Tamoxifen | 2 | 2007 | 48 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 5 | 2014 | 711 | 0.090 |
Why?
|
| Cohort Studies | 4 | 2017 | 1687 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2013 | 248 | 0.090 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2008 | 4 | 0.080 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2008 | 6 | 0.080 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2008 | 8 | 0.080 |
Why?
|
| Insulin Resistance | 3 | 2019 | 449 | 0.080 |
Why?
|
| Solubility | 2 | 2007 | 38 | 0.080 |
Why?
|
| Genetic Variation | 1 | 2010 | 251 | 0.080 |
Why?
|
| CpG Islands | 3 | 2015 | 44 | 0.080 |
Why?
|
| North Carolina | 1 | 2013 | 1423 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2016 | 155 | 0.080 |
Why?
|
| Monkey Diseases | 1 | 2008 | 18 | 0.080 |
Why?
|
| Genistein | 2 | 2008 | 14 | 0.080 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2008 | 19 | 0.080 |
Why?
|
| Demography | 3 | 2016 | 104 | 0.080 |
Why?
|
| Heart Failure | 1 | 2014 | 568 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2007 | 13 | 0.080 |
Why?
|
| Vasculitis | 1 | 2007 | 23 | 0.080 |
Why?
|
| Receptors, Chemokine | 1 | 2007 | 9 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2007 | 28 | 0.080 |
Why?
|
| Biopsy | 3 | 2016 | 241 | 0.080 |
Why?
|
| Adrenergic Agonists | 1 | 2007 | 5 | 0.080 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2007 | 18 | 0.080 |
Why?
|
| Ethinyl Estradiol | 1 | 2007 | 6 | 0.080 |
Why?
|
| Prognosis | 3 | 2018 | 1362 | 0.070 |
Why?
|
| Blood Proteins | 1 | 2006 | 18 | 0.070 |
Why?
|
| Vagina | 1 | 2007 | 47 | 0.070 |
Why?
|
| Arousal | 2 | 2005 | 19 | 0.070 |
Why?
|
| Vegetables | 1 | 2006 | 35 | 0.070 |
Why?
|
| Progesterone Congeners | 2 | 2002 | 15 | 0.070 |
Why?
|
| Placebos | 3 | 2014 | 61 | 0.070 |
Why?
|
| Oxidative Phosphorylation | 2 | 2016 | 22 | 0.070 |
Why?
|
| Epithelial Cells | 3 | 2013 | 138 | 0.070 |
Why?
|
| Administration, Oral | 4 | 2007 | 169 | 0.070 |
Why?
|
| Coronary Circulation | 1 | 2005 | 30 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2007 | 249 | 0.070 |
Why?
|
| Coronary Disease | 1 | 2006 | 200 | 0.070 |
Why?
|
| Age Factors | 3 | 2015 | 1108 | 0.070 |
Why?
|
| Physical Conditioning, Animal | 2 | 2017 | 32 | 0.070 |
Why?
|
| Serum | 1 | 2004 | 20 | 0.060 |
Why?
|
| Adrenal Cortex | 1 | 2004 | 2 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 1 | 2004 | 139 | 0.060 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 2004 | 9 | 0.060 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2018 | 93 | 0.060 |
Why?
|
| Genitalia, Male | 1 | 2004 | 3 | 0.060 |
Why?
|
| Genitalia, Female | 1 | 2004 | 4 | 0.060 |
Why?
|
| Creatinine | 2 | 2017 | 174 | 0.060 |
Why?
|
| Logistic Models | 2 | 2018 | 727 | 0.060 |
Why?
|
| Hydroxyindoleacetic Acid | 2 | 2014 | 17 | 0.060 |
Why?
|
| Receptors, Steroid | 3 | 2011 | 7 | 0.060 |
Why?
|
| Mice, Knockout | 2 | 2018 | 425 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 1 | 2004 | 212 | 0.060 |
Why?
|
| Densitometry | 1 | 2003 | 8 | 0.060 |
Why?
|
| Proportional Hazards Models | 2 | 2017 | 709 | 0.060 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2014 | 37 | 0.060 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 196 | 0.060 |
Why?
|
| Cross-Over Studies | 3 | 2008 | 94 | 0.060 |
Why?
|
| Comorbidity | 2 | 2016 | 540 | 0.060 |
Why?
|
| Prevalence | 2 | 2017 | 896 | 0.060 |
Why?
|
| Esterification | 1 | 2002 | 3 | 0.060 |
Why?
|
| E-Selectin | 1 | 2002 | 20 | 0.060 |
Why?
|
| Endothelin-1 | 1 | 2002 | 17 | 0.060 |
Why?
|
| Stereotyped Behavior | 1 | 2002 | 14 | 0.060 |
Why?
|
| Bone Remodeling | 1 | 2002 | 8 | 0.060 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2002 | 35 | 0.060 |
Why?
|
| Cell Adhesion Molecules | 1 | 2002 | 45 | 0.050 |
Why?
|
| Hydrocortisone | 3 | 2008 | 61 | 0.050 |
Why?
|
| Reproduction | 1 | 2002 | 10 | 0.050 |
Why?
|
| Telomerase | 1 | 2002 | 21 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2013 | 641 | 0.050 |
Why?
|
| Muscular Atrophy | 2 | 2012 | 67 | 0.050 |
Why?
|
| United States | 3 | 2017 | 3630 | 0.050 |
Why?
|
| Cricetinae | 2 | 2014 | 58 | 0.050 |
Why?
|
| Survival Analysis | 2 | 2018 | 440 | 0.050 |
Why?
|
| Lactalbumin | 2 | 2014 | 10 | 0.050 |
Why?
|
| Caseins | 2 | 2014 | 13 | 0.050 |
Why?
|
| Receptors, LDL | 1 | 2002 | 64 | 0.050 |
Why?
|
| Mass Spectrometry | 2 | 2012 | 99 | 0.050 |
Why?
|
| Rats | 2 | 2014 | 1604 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2016 | 1218 | 0.050 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2019 | 6 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2017 | 3099 | 0.050 |
Why?
|
| Pituitary-Adrenal System | 2 | 2013 | 24 | 0.040 |
Why?
|
| Lipoproteins, LDL | 2 | 2010 | 77 | 0.040 |
Why?
|
| Hypothalamo-Hypophyseal System | 2 | 2013 | 34 | 0.040 |
Why?
|
| Triglycerides | 2 | 2011 | 214 | 0.040 |
Why?
|
| Linear Models | 2 | 2012 | 426 | 0.040 |
Why?
|
| Heart Rate | 2 | 2014 | 315 | 0.040 |
Why?
|
| Lymphocyte Subsets | 1 | 2019 | 7 | 0.040 |
Why?
|
| Thymus Gland | 1 | 2019 | 15 | 0.040 |
Why?
|
| Blood Cell Count | 1 | 2019 | 26 | 0.040 |
Why?
|
| Hematopoiesis | 1 | 2019 | 34 | 0.040 |
Why?
|
| Antibody Formation | 1 | 2019 | 39 | 0.040 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2018 | 12 | 0.040 |
Why?
|
| Autopsy | 1 | 2018 | 37 | 0.040 |
Why?
|
| Microscopy | 1 | 2018 | 27 | 0.040 |
Why?
|
| Gonadal Steroid Hormones | 2 | 2011 | 28 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2014 | 2019 | 0.040 |
Why?
|
| Myocardial Revascularization | 1 | 2018 | 37 | 0.040 |
Why?
|
| Ki-67 Antigen | 2 | 2012 | 29 | 0.040 |
Why?
|
| Strontium | 1 | 2017 | 5 | 0.040 |
Why?
|
| Osteocalcin | 1 | 2017 | 9 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2013 | 680 | 0.040 |
Why?
|
| Theca Cells | 1 | 2017 | 9 | 0.040 |
Why?
|
| Lipid Metabolism | 1 | 2018 | 100 | 0.040 |
Why?
|
| Hormones | 1 | 2017 | 19 | 0.040 |
Why?
|
| Femur Neck | 1 | 2017 | 19 | 0.040 |
Why?
|
| Health Status Indicators | 1 | 2018 | 67 | 0.040 |
Why?
|
| Cholesterol, LDL | 1 | 2018 | 157 | 0.040 |
Why?
|
| Administration, Intravaginal | 2 | 2007 | 6 | 0.040 |
Why?
|
| Multigene Family | 2 | 2007 | 47 | 0.040 |
Why?
|
| Rats, Inbred F344 | 1 | 2017 | 125 | 0.040 |
Why?
|
| Coronary Angiography | 1 | 2018 | 136 | 0.040 |
Why?
|
| Alginates | 1 | 2017 | 49 | 0.040 |
Why?
|
| Receptors, Progesterone | 2 | 2008 | 45 | 0.040 |
Why?
|
| Cell Transplantation | 1 | 2017 | 63 | 0.040 |
Why?
|
| Pharmacogenetics | 1 | 2017 | 35 | 0.040 |
Why?
|
| Reference Values | 1 | 2017 | 224 | 0.040 |
Why?
|
| Hot Flashes | 1 | 2017 | 46 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2018 | 469 | 0.040 |
Why?
|
| Models, Biological | 2 | 2011 | 373 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2018 | 447 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2017 | 143 | 0.040 |
Why?
|
| Cell Respiration | 1 | 2016 | 21 | 0.040 |
Why?
|
| Osteoblasts | 1 | 2016 | 46 | 0.040 |
Why?
|
| Waist Circumference | 1 | 2016 | 89 | 0.040 |
Why?
|
| Lod Score | 1 | 2016 | 71 | 0.040 |
Why?
|
| Quantitative Trait Loci | 1 | 2016 | 140 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2016 | 138 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 172 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2011 | 726 | 0.030 |
Why?
|
| Matrix Metalloproteinase 8 | 1 | 2015 | 6 | 0.030 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2015 | 5 | 0.030 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2015 | 6 | 0.030 |
Why?
|
| Interleukin-7 | 1 | 2015 | 11 | 0.030 |
Why?
|
| Ribosomes | 1 | 2015 | 10 | 0.030 |
Why?
|
| Lymphoid Tissue | 1 | 2015 | 10 | 0.030 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2015 | 24 | 0.030 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2015 | 22 | 0.030 |
Why?
|
| Menopause, Premature | 1 | 2015 | 8 | 0.030 |
Why?
|
| Animal Feed | 2 | 2005 | 14 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2015 | 46 | 0.030 |
Why?
|
| Triiodothyronine | 1 | 2014 | 7 | 0.030 |
Why?
|
| Thyrotropin | 1 | 2014 | 9 | 0.030 |
Why?
|
| Thyroxine | 1 | 2014 | 16 | 0.030 |
Why?
|
| Asian Continental Ancestry Group | 1 | 2015 | 110 | 0.030 |
Why?
|
| Autophagy | 1 | 2015 | 53 | 0.030 |
Why?
|
| Thyroid Gland | 1 | 2014 | 13 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2014 | 103 | 0.030 |
Why?
|
| Cartilage, Articular | 1 | 2015 | 68 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 2018 | 412 | 0.030 |
Why?
|
| Guinea Pigs | 1 | 2014 | 12 | 0.030 |
Why?
|
| Lanthanum | 1 | 2014 | 3 | 0.030 |
Why?
|
| Phosphorus, Dietary | 1 | 2014 | 3 | 0.030 |
Why?
|
| Endpoint Determination | 1 | 2014 | 19 | 0.030 |
Why?
|
| Glucuronidase | 1 | 2014 | 9 | 0.030 |
Why?
|
| Somatomedins | 1 | 2014 | 5 | 0.030 |
Why?
|
| Risk | 1 | 2015 | 289 | 0.030 |
Why?
|
| Body Weights and Measures | 1 | 2014 | 22 | 0.030 |
Why?
|
| Thigh | 1 | 2014 | 39 | 0.030 |
Why?
|
| Dogs | 1 | 2014 | 117 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2014 | 34 | 0.030 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2014 | 40 | 0.030 |
Why?
|
| Glucose | 1 | 2015 | 163 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2014 | 33 | 0.030 |
Why?
|
| Rabbits | 1 | 2014 | 185 | 0.030 |
Why?
|
| Transcription Initiation Site | 1 | 2013 | 10 | 0.030 |
Why?
|
| Glutathione Transferase | 1 | 2013 | 18 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2013 | 23 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2013 | 43 | 0.030 |
Why?
|
| Cause of Death | 1 | 2014 | 220 | 0.030 |
Why?
|
| Receptors, Adiponectin | 1 | 2013 | 3 | 0.030 |
Why?
|
| Muramidase | 1 | 2013 | 8 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2013 | 46 | 0.030 |
Why?
|
| Tunica Media | 1 | 2013 | 29 | 0.030 |
Why?
|
| Echocardiography | 1 | 2014 | 140 | 0.030 |
Why?
|
| Tunica Intima | 1 | 2013 | 59 | 0.030 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2013 | 3 | 0.030 |
Why?
|
| RANK Ligand | 1 | 2013 | 4 | 0.030 |
Why?
|
| Propanolamines | 1 | 2013 | 11 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2014 | 118 | 0.030 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2013 | 20 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2013 | 65 | 0.030 |
Why?
|
| Leptin | 1 | 2013 | 66 | 0.030 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2013 | 36 | 0.030 |
Why?
|
| Astrocytes | 1 | 2013 | 49 | 0.030 |
Why?
|
| Temporal Lobe | 1 | 2013 | 41 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2013 | 28 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2013 | 36 | 0.030 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2013 | 59 | 0.030 |
Why?
|
| Isotonic Contraction | 1 | 2012 | 8 | 0.030 |
Why?
|
| Myofibrils | 1 | 2012 | 10 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2013 | 98 | 0.030 |
Why?
|
| Norepinephrine | 1 | 2013 | 73 | 0.030 |
Why?
|
| Transplantation, Heterologous | 1 | 2013 | 121 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2014 | 501 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2013 | 160 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2013 | 128 | 0.030 |
Why?
|
| Databases, Protein | 1 | 2012 | 13 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 747 | 0.030 |
Why?
|
| Species Specificity | 1 | 2012 | 84 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2012 | 56 | 0.030 |
Why?
|
| Cercopithecidae | 1 | 2011 | 10 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2013 | 276 | 0.030 |
Why?
|
| Range of Motion, Articular | 1 | 2013 | 177 | 0.030 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2011 | 5 | 0.030 |
Why?
|
| Phospholipases A2 | 1 | 2011 | 22 | 0.030 |
Why?
|
| Claudins | 1 | 2011 | 8 | 0.030 |
Why?
|
| Aorta | 2 | 2002 | 103 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2013 | 141 | 0.030 |
Why?
|
| Lactation | 1 | 2011 | 14 | 0.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2011 | 21 | 0.030 |
Why?
|
| Cadherins | 1 | 2011 | 24 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 2011 | 47 | 0.030 |
Why?
|
| Proteomics | 1 | 2012 | 92 | 0.030 |
Why?
|
| Cognition | 1 | 2015 | 526 | 0.030 |
Why?
|
| Reference Standards | 1 | 2011 | 30 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2011 | 84 | 0.020 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2011 | 14 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2011 | 108 | 0.020 |
Why?
|
| Epidemiologic Studies | 1 | 2010 | 20 | 0.020 |
Why?
|
| ROC Curve | 1 | 2011 | 149 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2013 | 859 | 0.020 |
Why?
|
| Survival Rate | 1 | 2013 | 795 | 0.020 |
Why?
|
| Phosphorus | 1 | 2010 | 11 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2011 | 106 | 0.020 |
Why?
|
| Collagenases | 1 | 2010 | 9 | 0.020 |
Why?
|
| Epitopes | 1 | 2010 | 21 | 0.020 |
Why?
|
| Matrix Metalloproteinases | 1 | 2010 | 9 | 0.020 |
Why?
|
| Pedigree | 1 | 2010 | 133 | 0.020 |
Why?
|
| Immunochemistry | 1 | 2010 | 8 | 0.020 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2010 | 5 | 0.020 |
Why?
|
| Endopeptidases | 1 | 2010 | 26 | 0.020 |
Why?
|
| Cardiovascular System | 1 | 2010 | 39 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2018 | 3111 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2009 | 13 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2009 | 21 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2009 | 60 | 0.020 |
Why?
|
| Mitochondria | 1 | 2011 | 174 | 0.020 |
Why?
|
| Anthropometry | 1 | 2009 | 82 | 0.020 |
Why?
|
| Dexamethasone | 1 | 2009 | 42 | 0.020 |
Why?
|
| Cricetulus | 1 | 2008 | 17 | 0.020 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2008 | 34 | 0.020 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2008 | 11 | 0.020 |
Why?
|
| Social Dominance | 1 | 2008 | 18 | 0.020 |
Why?
|
| Pregnancy | 1 | 2011 | 815 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 2008 | 30 | 0.020 |
Why?
|
| Luteal Phase | 1 | 2008 | 22 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2008 | 55 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2008 | 86 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2010 | 799 | 0.020 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2007 | 17 | 0.020 |
Why?
|
| Intrauterine Devices, Medicated | 1 | 2007 | 5 | 0.020 |
Why?
|
| Europe | 1 | 2007 | 77 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2007 | 36 | 0.020 |
Why?
|
| Cell Line | 1 | 2008 | 449 | 0.020 |
Why?
|
| Contraceptive Agents, Female | 1 | 2007 | 15 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2007 | 126 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2007 | 225 | 0.020 |
Why?
|
| Steryl-Sulfatase | 1 | 2006 | 3 | 0.020 |
Why?
|
| Haplotypes | 1 | 2006 | 220 | 0.020 |
Why?
|
| Chromatography, Thin Layer | 1 | 2006 | 8 | 0.020 |
Why?
|
| Diet, Protein-Restricted | 1 | 2005 | 2 | 0.020 |
Why?
|
| Nitroglycerin | 1 | 2005 | 11 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 2005 | 54 | 0.020 |
Why?
|
| Estrus | 1 | 2005 | 5 | 0.020 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2005 | 22 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2005 | 145 | 0.020 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2004 | 10 | 0.020 |
Why?
|
| Cell Division | 1 | 2004 | 97 | 0.020 |
Why?
|
| Estrogen Antagonists | 1 | 2004 | 14 | 0.020 |
Why?
|
| Androgens | 1 | 2004 | 22 | 0.020 |
Why?
|
| Endometrial Neoplasms | 1 | 2004 | 34 | 0.020 |
Why?
|
| Radiography, Abdominal | 1 | 2004 | 16 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2004 | 43 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2002 | 23 | 0.010 |
Why?
|
| Hyperplasia | 1 | 2002 | 38 | 0.010 |
Why?
|
| Cholesterol Esters | 1 | 2002 | 37 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2002 | 51 | 0.010 |
Why?
|
| Ilium | 1 | 2002 | 13 | 0.010 |
Why?
|
| Horses | 1 | 2002 | 13 | 0.010 |
Why?
|
| Life Style | 1 | 2005 | 364 | 0.010 |
Why?
|
| Femur | 1 | 2002 | 67 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2002 | 35 | 0.010 |
Why?
|
| Probability | 1 | 2002 | 150 | 0.010 |
Why?
|
| Animals, Genetically Modified | 1 | 2002 | 67 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2002 | 85 | 0.010 |
Why?
|
| Dobutamine | 1 | 2002 | 43 | 0.010 |
Why?
|
| Smoking | 1 | 2005 | 427 | 0.010 |
Why?
|
| Myocardial Ischemia | 1 | 2002 | 83 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 532 | 0.010 |
Why?
|